Consistently, we found the mRNA expression of Rad51 was significantly down-regulated in renal tumours (clear cell carcinoma, chromophobe carcinoma, papillary carcinoma and metastatic clear cell carcinoma) compared with human normal renal tissues (Figure 3B). Here, RAD51 is linked to clear cell adenocarcinoma.